[Form 4] CAVA Group, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 overview: On 20 June 2025, CAVA Group, Inc. (ticker: CAVA) reported an insider equity transaction by director Philippe Amouyal.

• Security granted: 1,767 restricted stock units (RSUs) of CAVA common stock at a price of $0, reported as an acquisition (Code A).
• Vesting terms: The RSUs vest in full on the earlier of (i) 20 June 2026 or (ii) the business day before CAVA’s next annual shareholder meeting, contingent upon the director’s continued service.
• Post-transaction ownership: Amouyal now beneficially owns 18,074 CAVA shares, a figure that includes unvested RSUs.
• Ownership form: Direct.
• Signatory: Kenneth Robert Bertram acting under power of attorney; filing date 24 June 2025.

Investor take-away: The filing describes a routine equity compensation grant to a non-executive director. No open-market purchase or sale occurred and there was no cash consideration. While the award modestly increases insider ownership, the size (1,767 shares) is limited and lacks price signalling. Consequently, the filing has minimal immediate impact on CAVA’s valuation but does reinforce ongoing alignment between the board member and shareholders through equity-based incentives.

Positive

• Equity alignment strengthened: Director’s ownership increases to 18,074 shares, enhancing alignment with shareholder interests.
• Clear vesting schedule: RSUs fully vest within one year or before the next annual meeting, providing transparent incentive timing.

Negative

• Immaterial size: Only 1,767 RSUs granted, limiting any meaningful signal of insider conviction or value impact.
• No purchase price: Grant at $0 involves no personal capital commitment, reducing bullish interpretation.

Insights

Financial Analyst

TL;DR: Routine RSU award; minimal market impact, modest alignment boost.

The Form 4 shows a standard annual RSU grant to director Philippe Amouyal. The 1,767-share award, valued at $0 for reporting purposes, vests within roughly a year, matching common governance practice for newly public consumer companies. Post-grant ownership rises to 18,074 shares, still small relative to CAVA’s float, implying negligible dilution. Because there was no open-market buying or selling, the transaction offers little insight into insider sentiment. From a valuation standpoint, the filing is largely procedural, yet it marginally strengthens director–shareholder alignment via equity compensation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Amouyal Philippe

(Last) (First) (Middle)

C/O CAVA GROUP, INC.

14 RIDGE SQUARE NW, SUITE 500

(Street)

WASHINGTON DC 20016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CAVA GROUP, INC. [ CAVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/20/2025		A(1)		1,767	A	$0	18,074(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSU"), which vest in full on the earlier of (i) June 20, 2026 and (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the "Issuer"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement.

2. Includes unvested RSUs.

Remarks:

	/s/ Kenneth Robert Bertram, as Attorney-in-Fact	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CAVA shares did Director Philippe Amouyal receive on 20 June 2025?

He received 1,767 restricted stock units, each convertible into one common share upon vesting.

When will the newly granted RSUs to CAVA Director Amouyal vest?

They vest in full on the earlier of 20 June 2026 or the business day before the next CAVA annual shareholder meeting, subject to continued service.

What is Philippe Amouyal’s total beneficial ownership of CAVA after the transaction?

Following the grant, he beneficially owns 18,074 shares, inclusive of unvested RSUs.

Was there any cash consideration or open-market purchase involved in this Form 4 filing?

No. The shares were granted at $0 as part of an equity compensation package; no shares were bought or sold on the open market.

Does this Form 4 indicate insider buying sentiment for CAVA stock?

Not necessarily. The filing reflects a routine compensation grant, so it does not convey voluntary insider buying signals.